Preview

Pfizer - Financial Analysis

Good Essays
Open Document
Open Document
2555 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pfizer - Financial Analysis
Name: Khiem Nguyen
FINANCIAL ANALYSIS REPORT (Draft 1)
For
PFIZER INC.
Introduction and Shareholder Analysis
Pfizer (NYSE: PFE) is involved in the development, manufacturing and marketing of pharmaceutical products. The industry is intensely competitive. There are a few unique characteristics. Pharmaceutical products have long and expensive development periods – upwards of ten years and $100 million depending on the nature of the drug and the scope of the clinical trials process. In order to encourage companies to engage in innovation, companies are given lengthy patent protection for their drugs upon receiving regulatory approval. This allows them to charge monopoly rents so that they may recover the development cost. A product brought to market is often highly lucrative, so success in the industry depends largely on the firm’s ability to bring product to market and capitalize on the monopoly rents.
According to MSN Moneycentral, Pfizer’s share price closed on November 19, 2009 at $18.11. Over the past two years, Pfizer shares have generally declined. The stock ended November 2007 at $27.49, meaning that it has fallen 34% over the past two years. In that same span, the S&P 500 has declined around 21%. In order to compare the performance of Pfizer to the performance of the market, these figures need to be adjusted for risk. Pfizer’s beta is 0.76. Therefore, if the market declined 21%, Pfizer should have declined (0.76)(21) = 16%. That Pfizer has dropped 34% indicates that the stock has underperformed dramatically for the past two years. Shareholders are not getting the returns they would have expected from Pfizer stock.
Liquidity and Solvency
Pfizer’s liquidity situation has deteriorated in recent years. In 2005, the company’s current ratio was 1.6:1. This improved to 2.2:1 in 2006 but has since fallen back to 1.6:1. Even though this ratio is below the rule of thumb ratio of 2:1, it’s still higher than its industry competitors such as

You May Also Find These Documents Helpful

  • Satisfactory Essays

    BUSN 5200 W4 Homework

    • 467 Words
    • 2 Pages

    Comments on liquidity: Cannot tell if these ratios are good or bad without more information on the company’s situation or past years.…

    • 467 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    The team viewed the video “Cost of Capital” as part of our weekly team discussion. In the video, Amil Singh discussed the cost of capital for Pfizer Inc. Pfizer Inc. is the world 's largest research-based pharmaceutical company that develops its own products in America. Pfizer revenue is about $65 billion with market gap close to $140 billion (John Wiley and Sons, 2012). The cost of capital is the "rate of return that capital could expect to earn in an alternative investment of equivalent risk" (Investopedia LLC, 2015). When the company researches and develops a new product it can take nearly eight to ten years before it hits the market and see a profit. In this paper, we will look at how Pfizer addresses its cost of capital and issues with research and development.…

    • 865 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Fda Research Paper

    • 2368 Words
    • 10 Pages

    Sauer, C., & Sauer, R. M. (2007, October). Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate? The Benefits of Privatizing the Drug Approval Process. Journal of Technology Transfer, 32(5), 509-524. doi:http://dx.doi.org/10.1007/s10961-007-9036-0…

    • 2368 Words
    • 10 Pages
    Better Essays
  • Powerful Essays

    This paper is a Macroeconomic Forecast Outline of Pfizer, Inc. This outline will identify main economic indicators for Pfizer as a business entity and as a representative of pharmaceutical industry. This paper will identify sources of various data collected based on economical activity and relationships between different economical indicators.…

    • 1711 Words
    • 7 Pages
    Powerful Essays
  • Better Essays

    Merck & Co

    • 1066 Words
    • 5 Pages

    Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launched 15 new products that earned $5.9 billion on sales of $32.7 billion. Furthermore, Merck may agree to license new drugs from other firms and with its larger capital and greater assets, can assume the risk of submitting the drug through various regulatory approval phases. If the drug becomes profitable, Merck can earn significant cash flows while paying a royalty to the licensor. However, most important is the option that Merck has in deciding when to abandon or continue on this project (deferability or optionality). If Merck reaches a point when its expected NPV is negative, it can simply abandon the project.…

    • 1066 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    The biggest change in Abbott’s balance sheet can be seen in the composition of its asset accounts. In 2006, % of the firm’s assets were current, while 69% were of the long-term variety. In 2010, however, the portion of current assets increased by 7%. This increase in current assets is most visible in cash and short-term investments (4% in 2006 to 9% in 2010) and corresponds with a higher level of uncertainty in today’s economy. The fact that Abbott Laboratories has chosen to increase the value of liquid assets on its balance sheet indicates low returns on long-term investments and a preference of keeping cash on hand rather than reinvesting in the business.…

    • 1840 Words
    • 8 Pages
    Powerful Essays
  • Powerful Essays

    Hobby Horse Minicase

    • 735 Words
    • 3 Pages

    Available cash, or rather the lack of it, is a critical problem facing the company. All of the liquidity ratios are showing signs of decline. The current ratio has been in decrease over the past 4 years, possibly due in part to rapid expansion and more recently to poor product selection. There has been a much sharper weakening over the past 2 years.…

    • 735 Words
    • 3 Pages
    Powerful Essays
  • Powerful Essays

    Pfizer Global Strategy

    • 1353 Words
    • 6 Pages

    Pfizer 's domestic core competency has been the innovation of new pharmaceutical products and the domestic strategy has been one of differentiation. The domestic industry is that of pharmaceutical products. The international market is very competitive, in particularly the research and development of new pharmaceutical products. There is an increase in pressure to be responsive to the needs of the industry, but also to reduction of costs; which brings in the strategy of transnational.…

    • 1353 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    The 20 years average of patent protection is not expected to be reduced, but the time that a “breakthrough products” exists on the market without any competition decreases continuously and that pushes pharmaceutical companies to research in new therapeutic areas…

    • 481 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    SANOFI

    • 3581 Words
    • 15 Pages

    Like products, industries go through life cycle phases. The widely accepted definition of “mature industry” describes the “mature industry” as one that may be at its peak or just past it. While earnings may be stable, growth prospects are few and far between. Mature industries are characterized by low price to earnings ratios (P/E) and high dividend yields. If we apply this definition to the pharmaceutical…

    • 3581 Words
    • 15 Pages
    Powerful Essays
  • Better Essays

    Pfizer Technology Strategy

    • 1161 Words
    • 5 Pages

    Pfizer has recently acquired a biopharmaceutical company named Wyeth. By purchasing Wyeth which specializes in vaccines, Pfizer has broadened their customer base by expanding their product line. This business practice aligns with Pfizer’s current pro-growth Strategy. It is clear, in most part; Pfizer’s business Strategy aligns with the wild wild west model of Industry Ecosystems. Pfizer if a relatively fast growing company, in an industry that thrives on making fast and furious technological discoveries, and they have a very high rate of customer retention due to patent protection.…

    • 1161 Words
    • 5 Pages
    Better Essays
  • Satisfactory Essays

    Pfizer Case Study

    • 5226 Words
    • 21 Pages

    Bibliography: "Background Information - ClinicalTrials.gov." Background Information - ClinicalTrials.gov. N.p., n.d. Web. 05 Nov. 2012. <http://clinicaltrials.gov/ct2/info/und>.…

    • 5226 Words
    • 21 Pages
    Satisfactory Essays
  • Powerful Essays

    Financial Statement Ana

    • 88402 Words
    • 354 Pages

    Our Financial Review is provided to assist readers in understanding the results of operations, financial condition and cash flows of Pfizer Inc. (the Company). It should be read in conjunction with the Consolidated Financial Statements and Notes to Consolidated Financial Statements. The discussion in this Financial Review contains forward-looking statements that involve substantial risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors such as those discussed in Part 1, Item 1A, “Risk Factors” of our 2011 Annual Report on Form 10-K and in the “Forward-Looking Information and Factors That May Affect Future Results”, “Our Operating Environment” and “Our Strategy” sections of this Financial Review. The Financial Review is organized as follows:…

    • 88402 Words
    • 354 Pages
    Powerful Essays
  • Powerful Essays

    Pfizer Strageic Plan

    • 11288 Words
    • 46 Pages

    Please bullet your responses. Staple the completed assignment; do not spend any money binding the assignment. Make sure to respond to every item.…

    • 11288 Words
    • 46 Pages
    Powerful Essays
  • Powerful Essays

    High Technology Acquisitions

    • 8869 Words
    • 36 Pages

    "We aim to gain leadership positions in key growing therapeutic areas and focus on delivering patient-centric, innovative therapies. We seek strong, long-term relationships that fit our goals and offer a shared vision “…

    • 8869 Words
    • 36 Pages
    Powerful Essays